On the contrary, Nras Q61R/+ expression in the context of indolent MM mouse model (Vκ*MYC) with concomitant activation of human MYC in GC B cells, resulted in high malignant MM with hyperactivation of the ERK and AKT pathways [198]. The gene discussed is NRAS; the disease is Miyoshi myopathy.